Back grey_arrow_rt.gif
 
Archived NATAP Articles from September 2002
 
null.gif
 
 
  1. Atazanavir Early Access Program - (9/30/02)

  2.  
  3. ICAAC - NEAT Study: new formulation of amprenavir - (9/30/02)

  4.  
  5. ICAAC - FTC+Efavirenz+ddI EC Once Daily; Tenofovir & mitochondrial DNA - (9/30/02)

  6.  
  7. ICAAC - Substitution of Efavirenz or Nevirapine for Protease Inhibitor (80% "success") - (9/30/02)

  8.  
  9. ICAAC - Kaletra: 4 year follow-up - (9/30/02)

  10.  
  11. ICAAC - Atazanavir: The Story Unfolds with Effectiveness Comparable To Efavirenz - (9/30/02)

  12.  
  13. ICAAC - Hepatitis ICAAC Report 1: identifying unknown routes for HCV transmission - (9/30/02)

  14.  
  15. ICAAC - 3TC Once Daily: equivalent to 3TC twice daily - (9/30/02)

  16.  
  17. ICAAC - 42nd ICAAC - New Entry Inhibitors In Early Development - (9/27/02)

  18.  
  19. ICAAC - 42nd ICAAC - New Discovery in HIV - (9/27/02)

  20.  
  21. Pegasys + Ribavirin: study results published - (9/27/02)

  22.  
  23. Effect of protease inhibitors on bone - Special report by Donald P. Kotler, MD, St Luke's-Roosevelt Medical Center, New York City - (9/26/02)

  24.  
  25. lipoWorkshop - HCV Viral Load Increases on HAART But CD4 Increase from HAART is Not Blunted: implications for when to begin HIV & HCV therapy - (9/26/02)

  26.  
  27. lipoWorkshop - HIV/Hepatitis & Insulin/Diabetes - (9/26/02)

  28.  
  29. lipoWorkshop - Body Composition Changes Observed in ACTG 384 - (9/26/02)

  30.  
  31. lipoWorkshop - Treating Diarrhea in HIV - (9/25/02)

  32.  
  33. lipoWorkshop - 36-week Safety and Tolerability Study of Extended-Release Niacin (ERN) for the Treatment of Elevated Triglycerides in HIV - (9/25/02)

  34.  
  35. lipoWorkshop - Nukes, Fat Loss, Mitochondrial Toxicity, Lactate - discussed below - (9/25/02)

  36.  
  37. lipoWorkshop - Switch Study From Nelfinavir to Atazanavir - (9/24/02)

  38.  
  39. HEPATITIS B PRIMER - (9/24/02)

  40.  
  41. lipoWorkshop - Atazanavir: preliminary week 24 study results show no increase in glucose, cholesterol and triglycerides - (9/24/02)

  42.  
  43. lipoWorkshop - LIPODYSTROPHY WORKSHOP day 1 - (9/23/02)

  44.  
  45. FDA Approves Adefovir for Chronic Hepatitis B - (9/23/02)

  46.  
  47. OSTEOPENIA IN HIV: tests and markers to evaluate bone loss - (9/23/02)

  48.  
  49. HIV Infection Rate Is Skyrocketing - (9/19/02)

  50.  
  51. The HIV Update - (9/19/02)

  52.  
  53. Viral load in HCV RNA-positive pregnant women - (9/18/02)

  54.  
  55. Hep C & Pregnancy: risks for transmission - (9/18/02)

  56.  
  57. Organ (Liver) Transplants - (9/18/02)

  58.  
  59. ROCHE ANNOUNCES SUBMISSION OF REQUEST TO FDA FOR APPROVAL OF T-20 - (9/18/02)

  60.  
  61. Roche's ribavirin Copegus available in all EU Countries within months - (9/18/02)

  62.  
  63. Does Patient Gender Affect Human Immunodeficiency Virus Levels? - (9/13/02)

  64.  
  65. Once-Daily HAART: Toward a New Treatment Paradigm - (9/13/02)

  66.  
  67. Cardiovascular Risk Associated With HIV Therapy: review by Judith Currier, MD - (9/13/02)

  68.  
  69. Does HAART harm the Liver? NNRTI-related or -unrelated hepatotoxicity? - (9/13/02)

  70.  
  71. Hepatitis Online Newsletter - (9/13/02)

  72.  
  73. Bananas May Beat Stroke Low-Potassium Diet Raises Stroke Risk - (9/13/02)

  74.  
  75. Alcohol and mitochondria: A dysfunctional relationship - (9/10/02)

  76.  
  77. Frequency of the HIV-protective CC chemokine receptor 5-32/32 genotype is increased in hepatitis C - (9/10/02)

  78.  
  79. Psychiatric disorders among veterans with hepatitis C infection - (9/10/02)

  80.  
  81. Interferon therapy prolonged life expectancy among chronic hepatitis C patients: for both responders & perhaps nonresponders - (9/10/02)

  82.  
  83. Low-Dose Prolonged Intermittent Interleukin-2 Adjuvant Therapy: Results of a Randomized Trial among Human Immunodeficiency Virus Positive Patients with Advanced Immune Impairment (<200 CD4s) - (9/09/02)

  84.  
  85. Serious Bradyarrhythmia That Was Possibly Induced by Lopinavir-Ritonavir in 2 Patients with Acquired Immunodeficiency Syndrome - (9/09/02)

  86.  
  87. HCV in HIV-Coinfection: ADAP, Access, Treatment Costs - (9/09/02)

  88.  
  89. Injection Drug Use Facilitates Hepatitis C Virus Infection of Peripheral Blood Mononuclear Cells - (9/09/02)

  90.  
  91. Researchers Document Rare Case of Second HIV Infection with Different Strain - (9/06/02)

  92.  
  93. Hepatitis C and Progression of HIV Disease - (9/06/02)

  94.  
  95. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection - (9/06/02)

  96.  
  97. Liver transplantation for patients on methadone maintenance - (9/06/02)

  98.  
  99. A Patient with HIV-1 Superinfection: safe sex, vaccine implications - (9/05/02)

  100.  
  101. Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol - (9/03/02)

  102.  
  103. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users - (9/03/02)

  104.  
  105. Virahep-c - (9/03/02)

  106.  
  107. HEPP (HIV & Hepatitis Education Prision Project) Subject: HCV and HCV in Prisions - Report Aug/Sept 2002 Vol. 5 Issue 8&9 - PDF Format - (9/03/02)

  108.